A plan to advance cooperation with development partners and establish a manufacturing framework for GCT-103 using SHED, with the aim of starting a company-sponsored clinical trial in Japan led by the company from 2025 onward. This is an individual development theme that includes the transition from pilot manufacturing to preparations for full-scale GMP manufacturing.